http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107629111-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-11
filingDate 2017-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107629111-B
titleOfInvention Liquid phase synthesis method of acetyl tetrapeptide-2
abstract The invention discloses a liquid phase synthesis method of acetyl tetrapeptide-2, which synthesizes 2N-terminal or side chain protection small-fragment peptides by a liquid phase synthesis method: Ac-D-Lys (Boc) -Asp (OtBu) -OH and H-Val-m-Tyr-OMe, condensing small-fragment peptide, finishing carbon-terminal amidation through ester exchange to obtain a target product with protection, deprotecting to obtain a crude product of acetyl tetrapeptide-2, and purifying the crude product to obtain a pure product of acetyl tetrapeptide-2. The synthetic method of the invention avoids the use of expensive resin in a solid phase method, overcomes the defects that the solid phase method uses protected amino acid in each step and uses too much reagent, reduces the cost, and has the advantages of simple synthetic method, energy saving, environmental protection and the like.
priorityDate 2017-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413982868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448078373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448844975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86669916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416546661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455858454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21705897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150277013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453025064

Total number of triples: 48.